Metraipolis › archive › dc_68cbd0444072

TP53 Functional-Domain-Specific Mutations Define Distinct Clinical Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase… — Europe PMC PMID:41753239

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41753239
DOI
10.3390/jcm15041552
License (as archived)
solo-consultazione
Archived
2026-11-05T19:29:43.798Z
SHA-256 of the archived text
6093d5c6ec76eb9887e6ac5cfcb7c224d6b7516f8a22c37573691d9ff5fb4820
Stable URL of this page
https://metraipolis.com/documento/dc_68cbd0444072

How to cite

TP53 Functional-Domain-Specific Mutations Define Distinct Clinical Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase… — Europe PMC PMID:41753239 — Europe PMC (en), https://europepmc.org/article/MED/41753239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68cbd0444072 (Metraipolis archive dc_68cbd0444072, sha256 6093d5c6ec76eb9887e6ac5cfcb7c224d6b7516f8a22c37573691d9ff5fb4820)
BibTeX
@misc{dc68cbd0444072,
  title = {TP53 Functional-Domain-Specific Mutations Define Distinct Clinical Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase… — Europe PMC PMID:41753239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41753239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68cbd0444072; sha256 6093d5c6ec76eb9887e6ac5cfcb7c224d6b7516f8a22c37573691d9ff5fb4820},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41753239. Agents can read the archived copy with the MCP tool read_document.